INTRAY DM-FUNGID is an interferon-gamma release assay (IGRA) for the detection of latent tuberculosis infection (LTBI) and active TB disease. The assay detects immune responses to Mycobacterium tuberculosis antigens, enabling accurate screening and diagnosis of both latent and active TB infection in...
Manufactured by
Bad Homburg, Germany
Our core value, that has helped to maintain long-term relations with our distributors all around the world.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
guangzhou biotron technolongy co.,ltd
China · 2 relevant products
INVITROS CO., LTD
South Korea · 2 relevant products
Era Biology (Canada) Co., Ltd
Canada · 1 relevant product
81 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 112 closest product alternatives
guangzhou biotron technolongy co.,ltd · China
Interferon-gamma release assay for detection of tuberculosis infection and exposure assessment in clinical and occupational health settings.
INVITROS CO., LTD · South Korea
Interferon-gamma release assay utilizing MP-CLIA technology for latent tuberculosis infection detection. Provides sensitive and specific detection in general hospital settings for tuberculosis screening.
Era Biology (Canada) Co., Ltd · Canada
IGL-200 is a diagnostic test for detecting invasive fungal diseases (IFD), enabling rapid and accurate identification of fungal pathogens in clinical samples. Designed for laboratory use, it supports timely clinical decision-making in immunocompromised patients at high risk of IFD complications.
109 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products